Presentation

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Presenter: Duk-Woo Park

April 28, 2018

REGISTER for free or LOG IN to view this content

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Coronary

ACS/AMI

Presentation

TCTAP 2018

OPTIMA Trial

P2Y12 inhibitor

Up Next

Presentation

Distal Left Main Bifurcation PCI: Concept is More Important

Presenter: Jung-Min Ahn

April 28, 2018

More slides +

Presentation

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

Presenter: Andrew McNeice

April 28, 2018

Presentation

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.